Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2012 Sep 7;21(11):2087–2094. doi: 10.1158/1055-9965.EPI-12-0616

Table 1.

Number and percent of women and samples included in analyses by age, ethnicity and personal characteristics

Variable Participants Samples
Contributed
Total Count 778
(100.0%)
1780
(100.0%)
Age (mean, sd) 52.3 (10.9) 53.5 (10.9)
Age < 45 190 (24.4%) 370 (20.8%)
45 ≤ Age < 55 276 (35.5%) 635 (35.7%)
55 ≤ Age < 65 215 (27.6%) 513 (28.8%)
Age ≥ 65 97 (12.5%) 262 (14.7%)
Non-White Race 78 (10.0%) 159 (8.9%)
  Black 10 (1.3%) 18 (1.0%)
  Asian 22 (2.8%) 42 (2.4%)
  Other 46 (5.9%) 99 (5.6%)
Hispanic 36 (4.6%) 66 (3.7%)
Ashkenazi Jewish 152 (19.5%) 325 (18.3%)
Parous 520 (66.8%) 1186 (66.6%)
Hysterectomy 67 (8.6%) 156 (8.8%)
Tubal Ligation 103 (13.2%) 253 (14.2%)
Current Smoker 26 (3.3%) 58 (3.3%)
Current HRT Use 101 (13.0%) 252 (14.2%)
Current OC Use 39 (5.0%) 91 (5.1%)
   Discontinuous OC 21 (2.7%) 48 (2.7%)
   Continuous OC 18 (2.3%) 43 (2.4%)
Family History of Br.Ca. 586 (75.3%) 1340 (75.3%)
Family History of Ov.Ca. 335 (43.1%) 792 (44.5%)
Personal HX of BC 134 (17.2%) 254 (14.3%)
Deleterious mutation 138 (17.7%) 261 (14.7%)